Regulation of the cholesterol ester cycle and progesterone synthesis by juvenile hormone in MA-10 Leydig tumor cells

We had previously reported that juvenile hormone III (JH III) and the JH analogue 2-(4-phenoxy phenoxy)-ethoxytetrahydropyran exert inhibitory effects on progesterone synthesis by blocking cAMP production in hCG-stimulated MA-10 Leydig tumor cells. In the present study, the effects of JH analogue up...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autor principal: Vladusic, E.A
Otros Autores: Pignataro, O.P, Bussmann, L.E, Charreau, E.H
Formato: Capítulo de libro
Lenguaje:Inglés
Publicado: 1995
Materias:
Acceso en línea:Registro en Scopus
DOI
Handle
Registro en la Biblioteca Digital
Aporte de:Registro referencial: Solicitar el recurso aquí
LEADER 13084caa a22010457a 4500
001 PAPER-19047
003 AR-BaUEN
005 20230518205024.0
008 190411s1995 xx ||||fo|||| 00| 0 eng|d
024 7 |2 scopus  |a 2-s2.0-0028894178 
024 7 |2 cas  |a 20 hydroxycholesterol, 29913-75-5; 25 hydroxycholesterol, 2140-46-7; 3 decyldimethylsilyl n [2 (4 methylphenyl) 1 phenylethyl]propionamide, 78934-83-5; 3(or 17)beta hydroxysteroid dehydrogenase, 9015-81-0; aminoglutethimide, 125-84-8; bucladesine, 16980-89-5, 362-74-3; cholesterol esterase, 9026-00-0; cholesterol monooxygenase (side chain cleaving), 37292-81-2; chorionic gonadotropin, 9002-61-3; pregnenolone, 145-13-1; 2-(4-phenoxyphenoxy)ethoxytetrahydropyran; 25-hydroxycholesterol, 2140-46-7; Bucladesine, 362-74-3; Cholesterol Esterase, EC 3.1.1.13; Cholesterol Esters; Cholesterol, 57-88-5; Hydroxycholesterols; juvenile hormone III, 5255-04-9; Juvenile Hormones; Progesterone, 57-83-0; Pyrans; Sesquiterpenes 
040 |a Scopus  |b spa  |c AR-BaUEN  |d AR-BaUEN 
030 |a JSBBE 
100 1 |a Vladusic, E.A. 
245 1 0 |a Regulation of the cholesterol ester cycle and progesterone synthesis by juvenile hormone in MA-10 Leydig tumor cells 
260 |c 1995 
270 1 0 |m Vladusic, E.A.; Instituto de Biología y Medicina Experimental (IBYME)-CONICET Obligado 2490, Buenos Aires, 1428, Argentina 
506 |2 openaire  |e Política editorial 
504 |a Vladusic, Bussmann, Visconti, Stoka, Rodriguez, Gros, Charreau, Effects of juvenile hormone on mammalian steroidogenesis (1994) J. Steroid Biochem. Molec. Biol., 50, pp. 181-187 
504 |a Freeman, Ascoli, Studies on the source of cholesterol used for steroid biosynthesis in cultured Leydig tumor cells (1982) J. Biol. Chem., 257, pp. 14,231-14,238 
504 |a Freeman, Ascoli, Desensitization of steroidogenesis in cultured Leydig tumor cells: role of cholesterol (1982) Proc. Natn. Acad. Sci. U.S.A., 79, pp. 7796-7800 
504 |a Freeman, Ascoli, The low-density lipoprotein pathway of cultured Leydig tumor cells (1983) Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 754, pp. 71-81 
504 |a Freeman, Regulation of the cholesterol ester cycle of cultured Leydig tumor cells (1987) Eur. J. Biochem., 164, pp. 351-356 
504 |a Freeman, Cyclic AMP mediated modification of cholesterol traffic in Leydig tumor cells (1987) J. Biol. Chem., 262, pp. 13,061-13,068 
504 |a Freeman, Plasma membrane cholesterol: removal and insertion into the membrane and utilization as substrate for steroidogenesis (1989) Endocrinology, 124, pp. 2527-2534 
504 |a Rodriguez, Gros, Stoka, Synthesis and activity of juvenile hormone analogues (JHA) (1989) Z. Naturforsch, 44 b, p. 983 
504 |a Ascoli, Characterization of several clonal lines of cultured Leydig tumor cells: gonadotropin receptors and steroidogenic responses (1981) Endocrinology, 108, pp. 88-95 
504 |a Freeman, Ascoli, Desensitization to gonadotropins in cultured Leydig tumor cells involves loss of gonadotropin receptors and decreased capacity for steroidogenesis (1981) Proc. Natn. Acad. Sci. U.S.A., 78, pp. 6309-6313 
504 |a Nagy, Freeeman, Cholesterol movement between the plasma membrane and the cholesteryl ester droplets of cultured Leydig tumor cells (1990) Biochem. J., 271, pp. 809-814 
504 |a Gocze, Freeman, A Cholesteryl ester hydrolase inhibitor blocks cholesterol translocation into the mitochondria of MA-10 Leydig tumor cells (1992) Endocrinology, 131, pp. 2972-2978 
504 |a Resko, Norman, Niswender, Spies, The relationship between progestins and gonadotropins during the late luteal phase of the menstrual cycle in Rhesus monkeys (1974) Endocrinology, 94, pp. 128-135 
504 |a Steiner, Pagliara, Chase, Kipnis, Radioimmunoassay for cyclic nucleotides (1972) J. Biol. Chem., 247, pp. 1114-1120 
504 |a Lowry, Rosebrough, Farr, Randall, Protein measurement with the folin phenol reagent (1951) J. Biol. Chem., 193, pp. 265-275 
504 |a Kim, Sah, Doong, Grodzinsky, Fluorometric assay of DNA in cartilage explants using Hoechst 33258 (1988) Anal. Biochem., 174, pp. 168-176 
504 |a Ross, Go, Heider, Rothblat, Selective inhibition of acyl coenzyme A: cholesterol acyltransferase by compound 58-035 (1984) J. Biol. Chem., 259, pp. 815-819 
504 |a Nagy, Freeman, Effect of cholesterol transport inhibitors on steroidogenesis and plasma membrane cholesterol transport in cultured MA-10 Leydig tumor cells (1990) Endocrinology, 126, pp. 2267-2276 
504 |a Toaff, Schleyer, Strauss, Metabolism of 25-hydroxycholesterol by rat luteal mitochondria and dispersed cells (1982) Endocrinology, 111, pp. 1785-1792 
504 |a Quinn, Georgion, Payne, Differences in the control of sterol metabolism between mouse and rat Leydig cells (1985) Endocrinology, 116, pp. 2300-2305 
504 |a Simpson, Cholesterol side-chain cleavage, cytochrome P450, and the control of steroidogenesis (1979) Molec. Cell. Endocrinol., 13, pp. 213-227 
504 |a Lange, Ramos, Analysis of the distribution of cholesterol in the intact cell (1983) J. Biol. Chem., 258, pp. 15,130-15,134 
520 3 |a We had previously reported that juvenile hormone III (JH III) and the JH analogue 2-(4-phenoxy phenoxy)-ethoxytetrahydropyran exert inhibitory effects on progesterone synthesis by blocking cAMP production in hCG-stimulated MA-10 Leydig tumor cells. In the present study, the effects of JH analogue upon the biosynthetic pathway of progesterone synthesis have been examined. Our results demonstrated that JH analogue inhibited progesterone production even in the presence of 20-hydroxycholesterol or 25-hydroxycholesterol. Furthermore, although JH analogue inhibited pregnenolone production in hCG-stimulated MA-10 cells the activity of the 3β-hydroxysteroid dehydrogenase (3β-HSD) was unaffected. These data suggest that JH analogue might inhibit the steroidogenic pathway in Leydig tumor cells by inhibiting the activity of the cholesterol side chain cleavage (CSCC) enzymatic complex. The JH analogue was also evaluated for inhibitory actions on cholesterol availability. An important effect of this compound was the interference with the cellular process of plasma membrane cholesterol internalization. Moreover, JH analogue inhibited not only the use of cholesterol ester for steroid biosynthesis under Bt2cAMP stimulation, but also the cholesterol ester hydrolase (CEH) activity in MA-10 Leydig tumor cells. © 1995.  |l eng 
536 |a Detalles de la financiación: hydroxylatedc ompoundsn or hCG could revert the resynthesiiss lost to steroidogenesaisn d results in a inhibitory effect of the JH analogue. Both these net ester hydrolysis. The presence of JH analogue hydroxylatedc ompoundspassed though the plasma in Bt2cAMP-stimulatedce lls blocked this net ester membranea nd entered the mitochondriato become hydrolysis effect. Control experimentsw ere carried substrateso f the CSCC enzymes [19,20]T. hese out using Bt2cAMP in combination with amino-studies employedc oncentrationosf the inhibitor that gluthetimidea, CSCC inhibitor, with a similar inhibi-almost completelyb lockedsteroidogenesis. tory effect on net ester hydrolysis.T he blocking of Moreover,w ith the use of pregnenolonme etabolism steroidogenesuiss inga minogluthetimiddeid not affect inhibitors such as cyanoketone,w e determined a the increasesi n the activities of CEH and ACAT decreasei n pregnenolonep roductionin stimulated caused by BtzcAMP [5]T. o determinew hetherthe cells treatedw ith the JH analogue. inhibitory effect observedi n the presenceo f the JH These results, togethe.rw ith the previous determi-analogueis similar to the aminogluthetimideeff ect,w e nation of 3/3-HSD activity, led us to suggestt hat the determinedth e cholesteroel sterh ydrolasea ctivityof inhibitory effect could be related to an effect on intact ceils. These experimentws ere carried out using the CSCC enzymaticc omplex.In these studies,h ow-the 58-035 ACAT inhibitor, which preventsc holes-ever, a direct estimationo f CSCC activity was not terol ester resynthesis[ 17]a, nd CEH activity was performed. determined as the percentageo f cholesterol ester The availabilityo f c]holesterofol r steroidogenesis hydrolysed. The addition of both 58-035 and JH is regulatedb y several processesi,n cludingcellular analogueto Bt2 cAMP-stimulatedce llsdid not alter the uptakev ia lipoproteinre ceptorsr,e leasefr om esterified cholesteroel ster mass and decreasedC E hydrolysis storesi n lipid dropletsb y a cAMP-sensitivech olesterol to basal levels, indicating that JH analogue effects esteraset,r ansportt o mitochondriaa, nd translocation CEH activity. acrosst he outer to the inner mitochondriaml embrane [211. The proportion of cell cholesteroli n the plasma membrane,a nd the easy way in which radiolabeled cholesterocla nbe introducedse lectiveliyn tothis mem- brane, makes this molecule a strong candidatea s a plasma membranem arker[22]. In non-stimulatecde lls, most cholesteroils trans- ported to the plasma membrane where it remains indefinitelyS. teroidh ormone-synthesizicnegl ls divert cholesterolo, rdinarilyd estinedf or insertion into the membranet,o wardsthe steroid biosyntheticp athway and cause plasma membrane cholesterolt o become internalized [6].W e have found that JH analogue modifiedt he level of pH]cholesteruosl edto radiolabel the plasmam embranes,u ggestingth at the presenceo f the JH analoguea ffectedt he processd escribeda bove. Blocking of free cholesterouls agew ouldbe expectedto significantllyi mit steroidh ormones ynthesibs y MA-10 cells. Since the use of plasraam embranec holesteroal nd cholesteryel stersr equiresa functionings teroidogenic pathway, it seems likely that the inhibition of the pathway would account for the major effect of this compoundo n steroidogenesiDs.u ring the acute phase of steroidogenes(is0 --4h), cholesterosl toresprovide 73% of all suhstrate[ 5]. Cholesterol esters act as a readily available and rapidly mobilized source of cholesteroflo r steroido- genesis. Stimulation of MA-10 cells with trophic hormoneso r BtzcAMP, producesa n increasein choles- terol ester hydrolase( CEH) and ACAT activities [5]. This leads to an increasei:n the cholesteroel stercycle turnover. Thus, stimulatedce llsare able to convertc holesterol into steroidh ormonesc; onsequentlys,u bstratfeo r ester Acknowledgements--This work was supportedb y Fundaci6n Antorchaasn dC ONICET. We alsow antt o thankD r M. Ascolif or providingt he MA-10 Leydig cells and Dr B. Yamaguchif rom Sandoz,A rgentinafo r the provisiono f the ACAT inhibitor5 8035. 
593 |a Instituto de Biología y Medicina Experimental (IBYME)-CONICET Obligado 2490, Buenos Aires, 1428, Argentina 
690 1 0 |a 2 (4 PHENOXYPHENOXY)ETHOXYTETRAHYDROPYRAN 
690 1 0 |a 20 HYDROXYCHOLESTEROL 
690 1 0 |a 25 HYDROXYCHOLESTEROL 
690 1 0 |a 3 DECYLDIMETHYLSILYL N [2 (4 METHYLPHENYL) 1 PHENYLETHYL]PROPIONAMIDE 
690 1 0 |a 3(OR 17)BETA HYDROXYSTEROID DEHYDROGENASE 
690 1 0 |a AMINOGLUTETHIMIDE 
690 1 0 |a BUCLADESINE 
690 1 0 |a CHOLESTEROL ESTERASE 
690 1 0 |a CHOLESTEROL MONOOXYGENASE (SIDE CHAIN CLEAVING) 
690 1 0 |a CHORIONIC GONADOTROPIN 
690 1 0 |a ENZYME INHIBITOR 
690 1 0 |a JUVENILE HORMONE DERIVATIVE 
690 1 0 |a PREGNENOLONE 
690 1 0 |a UNCLASSIFIED DRUG 
690 1 0 |a ANIMAL CELL 
690 1 0 |a ARTICLE 
690 1 0 |a CHOLESTEROL TRANSPORT 
690 1 0 |a CONTROLLED STUDY 
690 1 0 |a ENZYME ACTIVITY 
690 1 0 |a LEYDIG CELL TUMOR 
690 1 0 |a MALE 
690 1 0 |a NONHUMAN 
690 1 0 |a PROGESTERONE SYNTHESIS 
690 1 0 |a STEROIDOGENESIS 
690 1 0 |a BUCLADESINE 
690 1 0 |a CELL MEMBRANE 
690 1 0 |a CHOLESTEROL 
690 1 0 |a CHOLESTEROL ESTERASE 
690 1 0 |a CHOLESTEROL ESTERS 
690 1 0 |a HYDROXYCHOLESTEROLS 
690 1 0 |a JUVENILE HORMONES 
690 1 0 |a LEYDIG CELL TUMOR 
690 1 0 |a PROGESTERONE 
690 1 0 |a PYRANS 
690 1 0 |a SESQUITERPENES 
690 1 0 |a SUPPORT, NON-U.S. GOV'T 
653 0 0 |a compound 58035, sandoz, Argentina 
700 1 |a Pignataro, O.P. 
700 1 |a Bussmann, L.E. 
700 1 |a Charreau, E.H. 
773 0 |d 1995  |g v. 52  |h pp. 83-90  |k n. 1  |p J. Steroid Biochem. Mol. Biol.  |x 09600760  |w (AR-BaUEN)CENRE-5799  |t Journal of Steroid Biochemistry and Molecular Biology 
856 4 1 |u https://www.scopus.com/inward/record.uri?eid=2-s2.0-0028894178&doi=10.1016%2f0960-0760%2894%2900149-G&partnerID=40&md5=c45d3c594715f3f2d2a777017fbaa01c  |y Registro en Scopus 
856 4 0 |u https://doi.org/10.1016/0960-0760(94)00149-G  |y DOI 
856 4 0 |u https://hdl.handle.net/20.500.12110/paper_09600760_v52_n1_p83_Vladusic  |y Handle 
856 4 0 |u https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_09600760_v52_n1_p83_Vladusic  |y Registro en la Biblioteca Digital 
961 |a paper_09600760_v52_n1_p83_Vladusic  |b paper  |c PE 
962 |a info:eu-repo/semantics/article  |a info:ar-repo/semantics/artículo  |b info:eu-repo/semantics/publishedVersion